๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interpreting cancer vaccine clinical trials

โœ Scribed by Glenn Dranoff

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
53 KB
Volume
1
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

โœฆ Synopsis

A number of cancer vaccine strategies have entered initial Phase I clinical testing. In this review, Dr. Glenn Dranoff discusses the prospects that appropriate immunologic monitoring of patients in these trials can help delineate important differences among the various immunization strategies and prioritize the most promising approaches for further clinical development.

๐Ÿ“œ SIMILAR VOLUMES

Clinical trials in testicular cancer
Clinical trials in testicular cancer
โœ Charles F. Kettering Prize; Lawrence H. Einhorn ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 289 KB ๐Ÿ‘ 2 views
Hybrid cell vaccination for cancer immun
Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma
โœ Uwe Trefzer; Guido Weingart; Yingwen Chen; Gunda Herberth; Karin Adrian; Helmut ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 364 KB ๐Ÿ‘ 2 views

Hybrid cell vaccination is a new cancer immune therapy approach that aims at recruiting T cell help for the induction of tumour specific cytolytic immunity. The vaccines are generated by fusion of the patients' tumour cells with allogeneic MHC class II bearing cells to combine the tumour's antigenic